Drug Trial Radar · NCT06841042
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
168
Planned (sponsor's estimate)
Start
Feb 2025
Primary completion
May 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- Sinocelltech Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).
Conditions
- System Lupus Erythematosus
Interventions
SCTB35 injectionBiological
SCTB35 will be subcutaneously administered at a dose as specified in the respective dose-escalation cohorts. Then, the RP2D and other appropriate doses of SCTB35 will be applied for the dose-expansion cohorts.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose-escalation part: Incidence rate of adverse event (AE)Time frame: From first dose to the 24 weeks
- Dose-expansion part:SRI-4Time frame: Up to Week 24
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, China · Recruiting
Xuanwu Hospital, Capital Medical University
Beijing, China · Not yet recruiting
Jilin Provincial People's Hospital
Changchun, China · Not yet recruiting
Guangdong Provincial People's Hospital
Guangzhou, China · Not yet recruiting
Zhejiang Provincial People's Hospital
Hangzhou, China · Not yet recruiting
The First People's Hospital of Jiujiang City
Jiujiang, China · Not yet recruiting
The First Affiliated Hospital of Kunming Medical University
Kunming, China · Not yet recruiting
Linfen Central Hospital
Linfen, China · Not yet recruiting
Mianyang Central Hospital
Mianyang, China · Not yet recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, China · Not yet recruiting
Pingxiang People's Hospital
Pingxiang, China · Not yet recruiting
Shanxi Bethune Hospital
Taiyuan, China · Not yet recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, China · Not yet recruiting
Xinxiang Central Hospital
Xinxiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.